Matches in Nanopublications for { ?s ?p "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 22 of
22
with 100 items per page.
- assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP217835.RAQ876IjiGZwaXso76Obkxr70U7u9XlxslfMPCqyZSzLQ130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217835.RAQ876IjiGZwaXso76Obkxr70U7u9XlxslfMPCqyZSzLQ130_provenance.
- assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1394187.RASESjrtPWcF78qW1kVUSlbNMlyb5V8oZoiQNMor4RvCs130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394187.RASESjrtPWcF78qW1kVUSlbNMlyb5V8oZoiQNMor4RvCs130_provenance.
- NP1394191.RAbL0ptQgwR_p11GfhxfIU_96x359hJVzakqZ9sW80wTs130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394191.RAbL0ptQgwR_p11GfhxfIU_96x359hJVzakqZ9sW80wTs130_provenance.
- NP1394192.RAZ4bqDF-Eh5DBBBUSskrJCHuLr0hc-MI4XgFExM_lJCU130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394192.RAZ4bqDF-Eh5DBBBUSskrJCHuLr0hc-MI4XgFExM_lJCU130_provenance.
- NP1394193.RAXTeIC2fB0JO1qORzMreq7ZhUYyyjSQhMKiveyN_12pY130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394193.RAXTeIC2fB0JO1qORzMreq7ZhUYyyjSQhMKiveyN_12pY130_provenance.
- NP1394194.RAUGXwnR1Vltfurx2mxUK5fzjBPMWXVR4aCmVAnWMVb7k130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394194.RAUGXwnR1Vltfurx2mxUK5fzjBPMWXVR4aCmVAnWMVb7k130_provenance.
- NP864344.RAkfrWviYpxiyTlfyqS4QS_hEvvmmvLrV8sKAwOUfmhCY130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864344.RAkfrWviYpxiyTlfyqS4QS_hEvvmmvLrV8sKAwOUfmhCY130_provenance.
- NP1004676.RACoBMRcCoFk9VLToxSDXfJmaZANRkBnxLSOHOOZ_yDjg130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004676.RACoBMRcCoFk9VLToxSDXfJmaZANRkBnxLSOHOOZ_yDjg130_provenance.
- assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP824197.RAo8IZ-VPt9t2Z2mXOl_iCMZSbvW2mP_oQYzwxrrNaWz0130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824197.RAo8IZ-VPt9t2Z2mXOl_iCMZSbvW2mP_oQYzwxrrNaWz0130_provenance.
- NP1000904.RAuIHFIQzwGW4pV4at_t1hpqE3IO27L_4TA9mWVX4ajho130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1000904.RAuIHFIQzwGW4pV4at_t1hpqE3IO27L_4TA9mWVX4ajho130_provenance.
- NP1394188.RAgVqBwKkhgh5kQY1ieTAWPpeorcjZU7knlFAjt9E1JuY130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394188.RAgVqBwKkhgh5kQY1ieTAWPpeorcjZU7knlFAjt9E1JuY130_provenance.
- NP221892.RA9LVH39XH3wjA1I3sWY4Tb0GDkV3XIcxO9o9TjCRM0XY130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221892.RA9LVH39XH3wjA1I3sWY4Tb0GDkV3XIcxO9o9TjCRM0XY130_provenance.
- NP221965.RA3ehumcLXn_bQrX_XW5jjyVAhQnoZp5CO-l0ZCAYfNoo130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221965.RA3ehumcLXn_bQrX_XW5jjyVAhQnoZp5CO-l0ZCAYfNoo130_provenance.
- NP986589.RAH2m7P2sXsSNn5chOzLdT-59XhYuEndNP8LxJbmNTF0s130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986589.RAH2m7P2sXsSNn5chOzLdT-59XhYuEndNP8LxJbmNTF0s130_provenance.
- NP1394189.RAG7PMyy4FPqy-4N8CO75Mbu9V6VqtjBxZvsC5bK1vgoU130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394189.RAG7PMyy4FPqy-4N8CO75Mbu9V6VqtjBxZvsC5bK1vgoU130_provenance.
- NP1394196.RAF6pjws8PFKgHhqGksPfQxNsR4Jg2g_Kh9TfADNSwlYM130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394196.RAF6pjws8PFKgHhqGksPfQxNsR4Jg2g_Kh9TfADNSwlYM130_provenance.
- NP990360.RA6d1NMVWxVp6XPLJ2QqdW1WAPqFLnSHJhggFfCf7n7BI130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP990360.RA6d1NMVWxVp6XPLJ2QqdW1WAPqFLnSHJhggFfCf7n7BI130_provenance.
- NP1394186.RA8yXtXRK2Mv2fe5cF9zS0F7Pvsu95oLURqwbdCbmiNSU130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394186.RA8yXtXRK2Mv2fe5cF9zS0F7Pvsu95oLURqwbdCbmiNSU130_provenance.
- NP1394190.RA1sujFbPerc7eNPQPwJKbyCex3wHFheI8mUPL5kjM114130_assertion description "[The two missense variants (Asp673Asn and Ser1369Ala) and two sequence variants (ACC-->ACT, Thr759Thr and a c-->t intron variant in position -3 of the exon 16 splice acceptor site) were examined for association with NIDDM and for a possible influence on insulin and C-peptide secretion after intravenous glucose and tolbutamide loads in a random sample of unrelated, healthy, young Danish Caucasians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394190.RA1sujFbPerc7eNPQPwJKbyCex3wHFheI8mUPL5kjM114130_provenance.